Themis Medicare share news, announcements and annual reports
NSE: THEMISMEDBSE: 530199Pharmaceuticals & BiotechnologySmall Cap
Themis Medicare Limited · Face value ₹1 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed May 1995 on BSE, Apr 2007 on NSE
Last close ₹94.83down ₹2.69 (2.76%)BSE ₹95.00
Share price at the NSE close on 30 Oct 2026. Previous close ₹97.52.
30 Oct: open ₹97.39, high ₹99.58, low ₹94.02
52-week range of traded prices to 30 Oct 2026
₹64.95Low, 30 Mar 2026₹140.60High, 7 Sep 2026
- Next results date: the board meets on 5 Nov 2026 to consider: financial results. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹873 Cr1,570th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 21.85
- P/E without one-offsPrice to earnings without one-off items. Market cap divided by core profit: the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, less one-off items (exceptional items and the result of businesses sold or closed). Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes ₹92 crore of one-off items, the largest of them in the quarter to Jun 2026.
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 2.19
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.53%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 10.0%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes ₹92 crore of one-off items, the largest of them in the quarter to Jun 2026.
- −13.0%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −10.5%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.25
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 60,90035.0% delivered
Themis Medicare share news and announcements
713 announcements, routine notices left out, newest first. Page 15 of 15.
Apr 2008
23 Apr · Board meeting
Company has informed that a meeting of the Board of Directors of the Company will be held on May 02, 2008 to discuss normal agenda of the business.22 Apr · Results
The Company would be publishing Audited Financial results for the period/ year ended 31st March 2008 within the time allowed i.e. by 30th June 2008. In view of above, unaudited financial results for period ended 31st March 2008 will not published/ submitted within 1 month of the end of the quarter.
Jan 2008
9 Jan · Board meeting
To consider and approve inter alia, the Unaudited financial Results together with limited review report submitted by the statutory auditors of the company for the quarter ended December 31, 2007. The board meeting will be preceded by Audit Committee Meeting to recommend the Unaudited Financial Results upto December 31, 2007.
Oct 2007
10 Oct · Board meeting
To consider and approve inter alia, the Unaudited Financial Results together with Limited Review Report submitted by the Statutory Auditors of the Company for the half year ended September 30, 2007. The Board Meeting will be preceded by Audit Committee Meeting to recommend the Unaudited Financial Results upto September 30, 2007.
Aug 2007
27 Aug · Corporate action
Company has announced the Book Closure dates from September 18, 2007 to September 22, 2007 (Both days inclusive) for the purpose of AGM to be held on September 22, 2007 as well as dividend payment for the year 2006-07.16 Aug · Meeting
Annual General meeting of the Company will be held on September 22, 2007.
Jul 2007
18 Jul · Management
At the Board Meeting held on July 18, 2007, Dr.Dinesh S. Patel, Mrs.Jayshree D. Patel and Dr.Sachin D. Patel were reappointed as Directors for a period of three years on revised remuneration. The aforesaid appointment and revised remuneration are subject to the provisions of the Companies Act, 1956.10 Jul · Board meeting
Meeting on 18 Jul 2007: “Unaudited financial results for quarter ended June 30, 2007”
Jun 2007
29 Jun · Dividend
Board, at its meeting held on June 29, 2007 has recommended 20% Dividend and transfer to General Reserve of Rs.600.00 Lacs for the year 2006-07.21 Jun · Board meeting
To consider, inter alia, the Audited Financial Results for the year ended March 31, 2007.1 Jun · Results
Company shall publish Audited Financial Results within a period of 3 month for the year ended on March 31, 2007 i.e. on or before June 30, 2007.
Apr 2007
30 Apr · Management
The Board Meeting of the Company was held on 27th April, 2007 to discuss the regular business affairs of the Company. Further, in the said meeting Mr.Rajneesh Anand was also appointed as Alternate Director of the Company pursuant to Section 313 of the Companies Act, 195623 Apr · Board meeting
To discuss the routine agenda of the business.